Beyond Amyloid: Systemic and Brain Frailty as Determinants of Response to Anti-Amyloid Therapy in Alzheimer's Disease-A Conceptual Review. [PDF]
Rus Prelog P +4 more
europepmc +1 more source
Anti-amyloid treatment in Alzheimer disease: updated implications for patients with cerebral amyloid angiopathy and other cerebrovascular conditions. [PDF]
Zupan M +3 more
europepmc +1 more source
Reduced diffusion associated with amyloid-related imaging abnormalities in three patients treated with donanemab. [PDF]
Schwartz NU +11 more
europepmc +1 more source
Longitudinal patterns of regional cerebral blood flow during anti-amyloid therapy in mild cognitive impairment: a pilot ASL MRI case series. [PDF]
Cheung EYW +7 more
europepmc +1 more source
Amyloid-related imaging abnormalities after immunotherapy: How might brain microvascular basement membrane components be involved? [PDF]
Vinters HV, Magaki S.
europepmc +1 more source
Real-world implementation of lecanemab in Korean patients at a tertiary memory clinic: Safety, ARIA risk, and early treatment patterns. [PDF]
Shin J +12 more
europepmc +1 more source
Spatial patterns of amyloid clearance after donanemab: A preliminary 12-month real-world amyloid PET study in Japanese patients with early Alzheimer's disease. [PDF]
Kujuro Y +6 more
europepmc +1 more source
Beyond the Cochrane review: Re-evaluating anti-amyloid therapy in Alzheimer's disease. [PDF]
Bernath MM +5 more
europepmc +1 more source
Dynamic imaging markers of incident microhemorrhages and superficial siderosis in the A4 study: A longitudinal person-interval analysis. [PDF]
Hill C +4 more
europepmc +1 more source

